Perspectives in Clinical Research

ORIGINAL ARTICLE
Year
: 2013  |  Volume : 4  |  Issue : 4  |  Page : 215--220

Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients


Dishank Patel1, Mira Desai1, AN Shah2, RK Dikshit1 
1 Department of Pharmacology, B. J. Medical College and Civil Hospital, Ahmedabad, Gujarat, India
2 Department of Medicine, B. J. Medical College and Civil Hospital, Ahmedabad, Gujarat, India

Correspondence Address:
Mira Desai
Department of Pharmacology, B. J. Medical College and Civil Hospital, Ahmedabad - 380 016, Gujarat
India

Purpose and Aim: Multi-drug resistance in treatment-experienced human immune deficiency virus (HIV) patients has been a major cause to first line antiretroviral therapy (ART) failure, necessitating a switch to second line therapy. In India, the second line treatment program is still relatively new with little experience and unclear outcomes. It is therefore, critical to assess the clinical, virological and immunological effectiveness and treatment outcome over the 1 st year of follow-up in the patients«SQ» switched to the second line ART at public sector tertiary care center. Materials and Methods: A prospective, observational study was carried out on HIV positive patients switched on second line ART from January 2010 to December 2010 at ART Centre, Civil Hospital, Ahmedabad. Demographic details, symptoms, adverse drug reactions (ADRs), second line ART regimens, CD4 count, and plasma viral load (PVL) were recorded in a case record form. Patients were followed-up monthly for 12 months. The data was analyzed by t-test, z-test, and Fisher-exact test. Results: Out of 126 patients, 82 received regimen V [zidovudine (ZDV) + lamivudine (3TC) + tenofovir (TDF) + boosted lopinavir (LPV/r)] and 44 received regimen Va [3TC + TDF + LPV/r]. A significant ( P < 0.0001) increase in mean body weight and marked reduction in number of patients (7) categorized as WHO stage III/IV was observed at 12 months of second line ART. Moreover, a significant immune reconstitution with increase in mean CD4 count and viral suppression (PVL < 400 copies/ml) in 103 (82%) patients ( P < 0.0001) was also observed. A total of 83 ADRs were observed in 69 (55%) patients, the most common being dyslipidemia (57) followed by anemia (9). Conclusion: Early treatment outcome with second line ART was good with 82% success rate in treatment experienced HIV patients. Dyslipidemia and anemia were the common ADRs observed.


How to cite this article:
Patel D, Desai M, Shah A N, Dikshit R K. Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients.Perspect Clin Res 2013;4:215-220


How to cite this URL:
Patel D, Desai M, Shah A N, Dikshit R K. Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients. Perspect Clin Res [serial online] 2013 [cited 2022 Aug 8 ];4:215-220
Available from: https://www.picronline.org/article.asp?issn=2229-3485;year=2013;volume=4;issue=4;spage=215;epage=220;aulast=Patel;type=0